Lymphoblastic Lymphoma

hematologic malignancy

Identifier: CI-CAN-00001100
Entity page: /cancer/lymphoblastic-lymphoma ↗
Edges: 353

Neighbours: 90 drugs10 trials
Drawn: 60 of 100 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Lymphoblastic Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived90 of 90show fewer
→ investigated in trials for	Cyclophosphamidesmall molecule 63 trials (19 active) · roll-up of the cancer and its descendants	—	—	Lymphoblastic Lymphoma	63	Observed	clinicaltrials	graph →
→ investigated in trials for	Methotrexatesmall molecule

Lymphoblastic Lymphoma studied in …STUDIED_INderived10 of 263show all (up to 200)
→ studied in	NCT07246213recruiting CAYA Cancer Retrospective Cohort Study · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07632014recruiting CAYA Cancer Prospective Cohort Study · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06514794Phase 2 · recruiting A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex) · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03779854Phase 2 · active not recruiting Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07819396Phase 2 · not yet recruiting Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04315324Phase 1/Phase 2 · active not recruiting Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) · condition mapped CURATED_BROADER · 263 trials mapped (66 active)	—	—	T Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07586618Phase 1 · recruiting First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect. · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 263 trials mapped (66 active)	—	—	Childhood Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07166419Phase 1 · active not recruiting Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia · condition mapped CURATED_BROADER · 263 trials mapped (66 active)	—	—	Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03959085Phase 3 · recruiting Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy · condition mapped ONTOLOGY_EXACT · 263 trials mapped (66 active)	—	—	B Lymphoblastic Lymphoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains